Tan Lines

science

One hormone, five receptors: why Melanotan II did so much more than tan

Published August 18, 2026

The forum lore around Melanotan II always emphasized its odd bundle of effects: tanning plus appetite suppression plus libido changes plus nausea and flushing. That bundle isn’t a quirk. It’s a map of the melanocortin receptor family, drawn by a molecule that couldn’t tell its targets apart.

One agonist, the whole melanocortin receptor family Melanotan II fans out to five melanocortin receptors: MC1R (pigment), MC3R, MC4R, MC5R, and MC2R which it largely spares. One agonist, the whole family Why Melanotan II “did everything” — one molecule, five melanocortin receptors. Melanotan II non-selective agonist MC1R melanocytes → eumelanin — the tan MC3R energy balance & metabolism MC4R appetite ↓ · sexual arousal (CNS) MC5R sebaceous & exocrine glands MC2R adrenal (ACTH) — largely spared activated by MT-II largely spared
One agonist, the whole family. Melanotan II activates MC1R (pigment), MC3R, MC4R and MC5R with real potency, and largely spares MC2R — the tan was only ever one output among several.

The receptor family

The body uses melanocortin peptides — α-MSH chief among them — as signals across at least five receptor types, each doing different work:

MC1R sits on melanocytes and drives pigment production. This is the tanning receptor, and it’s the one the original researchers cared about. Variants in the MC1R gene are why redheads burn: their receptor responds poorly, shifting output toward the sun-vulnerable red-yellow pigment pheomelanin instead of protective brown-black eumelanin.

MC3R and MC4R operate in the brain’s energy-balance circuits. MC4R signaling suppresses appetite — it is one of the most important known regulators of body weight, and rare MC4R mutations cause severe childhood obesity.

MC5R is involved in exocrine gland function, including sebum production.

MC2R is the outlier — it responds to ACTH in the adrenal system and MT-II largely leaves it alone.

MT-II is a shotgun

Melanotan II activates MC1R, MC3R, MC4R, and MC5R with meaningful potency. Read the receptor list against the forum lore and everything matches: MC1R gave the tan, MC4R gave the appetite suppression and (via central pathways) the libido effects, and central melanocortin activity broadly is consistent with the nausea, flushing, and yawning users reported. The compound “did everything” because it hit everything.

Why non-selectivity killed it as a tanning drug

A tanning medicine for the general public needs to touch MC1R and nothing else. A compound that also reaches into the brain’s weight and sexual-arousal circuitry can’t be a casual lifestyle drug — the off-target profile is the safety problem, independent of any manufacturing or dosing concerns.

The pharmaceutical world responded logically: it split the shotgun into rifles. The libido side effect was developed deliberately into bremelanotide (Vyleesi), an approved drug for hypoactive sexual desire disorder in women. The MC4R pathway became setmelanotide (Imcivree), approved for rare genetic obesity syndromes. And the MC1R goal survived in MT-II’s older sibling Melanotan I, which — as the next section of this site covers — became an approved photoprotective drug with a very narrow label.

One failed tanning peptide, three approved-drug lineages, zero of them available as the simple protective tan the project started with. That’s the scorecard the final pillar of this site tries to explain.